Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Fish and Richardson
Healthtrust
Express Scripts
Accenture
Moodys
McKesson
Julphar

Generated: October 23, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: canagliflozin

« Back to Dashboard

Canagliflozin

CASRN: 842133-18-0UNII:

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Teva
QuintilesIMS
Julphar
Mallinckrodt
Healthtrust
Harvard Business School
Express Scripts